Cingulate Inc. Reports First Quarter 2023 Financial Results

Additional $3 Million of Financing Proprietary PTR™ Manufacturing Processes Successfully Transferred to Societal CDMO Joint Commercialization Agreement for...

Related Keywords

Kansas , United States , Kansas City , Georgia , Lincoln Park , Melyssa Weible , Shanej Schaffer , Thomas Dalton , Matt Kreps , Peterj Werth , Exchange Commission , Darrow Associates , Elixir Health Public Relations , Lincoln Park Capital Fund , Drug Administration , Societal Cdmo Inc , Cingulate Inc , Company Board Of Directors , Nasdaq , Securities Exchange , Werth Family Investment Associates , Research Development Rd Expenses , Hc Wainwright Co , Manufacturing Processes , Successfully Transferred , Commercialization Agreement , Precision Timed Release , Cingulate Chairman , Family Investment Associates Provides , Completes Transfer , Federal Food , Drug Application , Hyperactivity Disorder , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Months Ended March , Public Relations , Nasdaq Cingw , Adhd , Anxiety , Cingulate , King , Phase 3 , Tx 1301 , Tx 2103 , Ktr , Bloomberg , Benzinga , Yahoo Finance , Seeking Alpha , Sj ,